Track topics on Twitter Track topics that are important to you
Denovo Biolabels GmbHspecializes in the
development of fluorescent
markers for bioanalytical
The R&D team combines
a profound knowledge in the
organic synthesis of
fluorescent dyes with many
years of practical experience
in life sciences
D - 48149
Robert Little, the Chief Business Officer of Denovo Biomarkers reveals to Fintan Walton the use of its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospect...
Denovo Biopharma, a San Diego-Beijing company, announced approval from the FDA to conduct a US Phase III trial of its lead drug in patients with Diffuse Large B Cell Lymphoma (DLBCL). The same trial (...
Deals and Financings China Resources Pharma announced plans to raise $368.5 million for a China life science investment fund; Chi-Med (Hutchison China MediTech) completed a $301 million secondary of...
A series of Ba2GdF7:Yb(3+), Tm(3+) nanophosphors (NPs) with dual-mode (down-conversion (DC) and upconversion (UC)) luminescence were successfully prepared by hydrothermal method at 180°C. The NPs hav...
The purpose of this post market study is to evaluate surgical implantation technique and the quality of repair of the cartilage defect with particulated juvenile cartilage in the human kne...
The objective of this study is to demonstrate the clinical performance of the Tryton Side Branch Stent used in conjunction with a commercially available Drug Eluting Stent (DES) to treat d...
Investigate the potential of tissue grafting that includes human mesenchymal stem cells in the repair and potential stabilization of the degenerative Lumbar disk and facet joint denovo and...
Rituximab is an attractive agent to bring to the upfront treatment of cGVHD due to its favorable toxicity profile, its proven efficacy in the treatment of steroid-refractory chronic GVHD, ...
Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-Dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-Term Steroids
All patients of the core study who are interested of being treated with EC-MPS will be included in an open-label extension study to collect further information on the long-term safety, tol...
Denovo Biolabels GmbHspecializes in the development of fluorescent markers for bioanalytical application
Denovo Biolabels GmbHspecializes in the development of fluorescentmarkers for bioanalytical applications. The R&D team combinesa profound knowledge in theorganic synthesis of fluorescent dyes with ma...
Founded in 2004, Benvenue Medical, Inc. provides next generation minimally invasive systems for spine repair that combine expandable implants with novel delivery instruments to pr...
Improvements in DNA sequencing and information technologies are driving an exponential increase in the amount of genomic data available. Despite the massive amounts of resources dedicated to accumulat...
We have published hundreds of Denovo Biolabels news stories on BioPortfolio along with dozens of Denovo Biolabels Clinical Trials and PubMed Articles about Denovo Biolabels for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Denovo Biolabels Companies in our database. You can also find out about relevant Denovo Biolabels Drugs and Medications on this site too.